$RLFTF (Related: DD opinion) Zaran from ya-h-oo
Post# of 653
Latest report from Wuhan, China...
For many hard-hit patients, lung function was still compromised half a year later. More than half of people who required ventilation had a reduced flow of oxygen from the lungs to the bloodstream, while about a quarter of others had that problem.
All of these people (in my opinion) need Aviptadil to help them restore lung function. They naturally should have had the dosages when they were actually infected with the virus to minimize or to ameliorate the virus's potential long term effects.
This is huge for the use of this pulmonary paradigm healer. The standard of care usage of VIP will be in the tens of millions if not more....
Once this drug/company becomes recognized for it's safety and efficacy, it will be hard pressed not to jump into double digits, regardless of the number of shares outstanding.